Yan Lin
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- RNA modifications and cancer 13
- RNA Research and Splicing 9
- Oncology 53
- Cancer Immunotherapy and Biomarkers 25
- Co-authors
- John M. Kirkwood (28 shared papers)Rong Liang (41 shared papers)Ahmad A. Tarhini (23 shared papers)Cindy Sander (18 shared papers)Lisa H. Butterfield (14 shared papers)Jiazhou Ye (30 shared papers)Jinyan Zhang (20 shared papers)Lianjie Lin (16 shared papers)
- Journals
- Journal of Clinical Oncology (22 papers)Journal of Cancer (8 papers)Journal for ImmunoTherapy of Cancer (5 papers)Frontiers in Oncology (5 papers)OncoTargets and Therapy (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yan Lin
224 papers receiving 5.4k citations
Yan Lin's Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 1.0k
- Oncology 1.4k
- Immunology 1.1k
- Molecular Biology 2.0k
- Hepatology 185
Countries citing papers authored by Yan Lin
This map shows the geographic impact of Yan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Lin more than expected).
Fields of papers citing papers by Yan Lin
This network shows the impact of papers produced by Yan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Lin. The network helps show where Yan Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 230 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 404 | |
| 2 | Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma Hit paper breakdown → | 2015 | 316 |
| 3 | 2014 | 245 | |
| 4 | 2013 | 174 | |
| 5 | 2012 | 168 | |
| 6 | 2019 | 164 | |
| 7 | 2012 | 128 | |
| 8 | 2010 | 114 | |
| 9 | 2014 | 111 | |
| 10 | 2018 | 102 | |
| 11 | 2020 | 102 | |
| 12 | 2018 | 98 | |
| 13 | 2005 | 75 | |
| 14 | 2008 | 65 | |
| 15 | 2016 | 60 | |
| 16 | 2014 | 58 | |
| 17 | 2019 | 56 | |
| 18 | 2012 | 55 | |
| 19 | 2011 | 53 | |
| 20 | 2013 | 53 |
About Yan Lin
Yan Lin is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 230 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Immunotherapy and Immune Responses (17 papers), Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (13 papers), MicroRNA in disease regulation (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Pregnancy and preeclampsia studies (9 papers) and RNA Research and Splicing (9 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.4k citations), Immunology (1.1k citations), Molecular Biology (2.0k citations) and Hepatology (185 citations). Yan Lin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include John M. Kirkwood, Rong Liang, Ahmad A. Tarhini, Cindy Sander, Lisa H. Butterfield, Jiazhou Ye, Jinyan Zhang, Lianjie Lin, Zhihui Liu and Yongqiang Li. Their work appears in journals such as Journal of Clinical Oncology, Journal of Cancer, Journal for ImmunoTherapy of Cancer, Frontiers in Oncology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.